390 related articles for article (PubMed ID: 28371195)
21. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
22. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
[TBL] [Abstract][Full Text] [Related]
23. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
[TBL] [Abstract][Full Text] [Related]
24. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
[TBL] [Abstract][Full Text] [Related]
26. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
27. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
28. Form follows function: Morphological and immunohistological insights into epithelial-mesenchymal transition characteristics of tumor buds.
Enderle-Ammour K; Bader M; Ahrens TD; Franke K; Timme S; Csanadi A; Hoeppner J; Kulemann B; Maurer J; Reiss P; Schilling O; Keck T; Brabletz T; Stickeler E; Werner M; Wellner UF; Bronsert P
Tumour Biol; 2017 May; 39(5):1010428317705501. PubMed ID: 28475002
[TBL] [Abstract][Full Text] [Related]
29. STAT3 Targets
Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X
Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441
[TBL] [Abstract][Full Text] [Related]
30. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
31. ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.
Cho HJ; Oh N; Park JH; Kim KS; Kim HK; Lee E; Hwang S; Kim SJ; Park KS
Mol Cancer Res; 2019 Nov; 17(11):2257-2266. PubMed ID: 31511359
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal-epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate.
Terragno M; Vetrova A; Semenov O; Sayan AE; Kriajevska M; Tulchinsky E
Sci Rep; 2024 Jan; 14(1):425. PubMed ID: 38172210
[TBL] [Abstract][Full Text] [Related]
33. ZEB1 induces ROS generation through directly promoting MCT4 transcription to facilitate breast cancer.
Han X; Long Y; Duan X; Liu Z; Hu X; Zhou J; Li N; Wang Y; Qin J
Exp Cell Res; 2022 Mar; 412(2):113044. PubMed ID: 35093305
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer.
Al Moustafa AE
Cell Adh Migr; 2013; 7(5):424-5. PubMed ID: 24152786
[TBL] [Abstract][Full Text] [Related]
35. Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis.
Addison JB; Voronkova MA; Fugett JH; Lin CC; Linville NC; Trinh B; Livengood RH; Smolkin MB; Schaller MD; Ruppert JM; Pugacheva EN; Creighton CJ; Ivanov AV
Mol Cancer Res; 2021 May; 19(5):784-798. PubMed ID: 33500360
[TBL] [Abstract][Full Text] [Related]
36. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
37. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
38. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
39. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.
Gong C; Zou J; Zhang M; Zhang J; Xu S; Zhu S; Yang M; Li D; Wang Y; Shi J; Li Y
Mol Carcinog; 2019 Oct; 58(10):1863-1875. PubMed ID: 31264274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
